Recent Advances in Inflammation and Allergy Drug Discovery
Subject Categories
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 57 |
| Total Docs. (3 years) | 48 |
| Total Refs. | 4,698 |
| Total Citations (3 years) | 81 |
| Citable Docs. (3 years) | 40 |
| Citations / Doc. (2 years) | 1.76 |
| Ref. / Doc. | 82.42 |
| % Female | 44.8% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Top 10 Most Cited Articles
Frequently Asked Questions
What is the impact factor of Recent Advances in Inflammation and Allergy Drug Discovery?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Recent Advances in Inflammation and Allergy Drug Discovery has an SJR of 0.391 and is ranked Q3.
What is the SJR and quartile of Recent Advances in Inflammation and Allergy Drug Discovery?
Recent Advances in Inflammation and Allergy Drug Discovery has an SJR (SCImago Journal Rank) of 0.391 and its best quartile is Q3.
What is the H-index of Recent Advances in Inflammation and Allergy Drug Discovery?
The H-index of Recent Advances in Inflammation and Allergy Drug Discovery is 40, meaning 40 of its articles have each been cited at least 40 times.
Is Recent Advances in Inflammation and Allergy Drug Discovery indexed in Scopus?
Yes. Recent Advances in Inflammation and Allergy Drug Discovery is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.